Federated Hermes
ABEO icon

Federated Hermes’s Abeona Therapeutics ABEO Stock Holding History

Federated Hermes’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17
Closed -$1K – 2239
2020
Q2 		$1K Buy
+17
New +$1.18K ﹤0.01% 2119
2018
Q2 		– Sell
-10
Closed -$4K – 2188
2018
Q1 		$4K Sell
10
-13
-57% -$4.83K ﹤0.01% 1985
2017
Q4 		$9K Buy
23
+19
+475% +$7.86K ﹤0.01% 1893
2017
Q3 		$2K Buy
+4
New +$1.07K ﹤0.01% 2037

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes's ABEO Position: Q3 2020 in Review

Federated Hermes sold out of Abeona Therapeutics (ABEO) in Q3 2020, closing a stake of 17 shares — an estimated $1K sold.

Federated Hermes first reported a position in ABEO in Q3 2017 and held it in 4 quarters. The position peaked at $9K in Q4 2017. 78 funds tracked by Wall St. Rank hold ABEO as of Q3 2020.

  • Federated Hermes reported no remaining Abeona Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Federated Hermes sold 17 Abeona Therapeutics shares in Q3 2020, an estimated $1K.
  • Federated Hermes first reported a position in Abeona Therapeutics in Q3 2017 and held it in 4 quarters.
  • Federated Hermes's Abeona Therapeutics position peaked at $9K in Q4 2017.
  • 78 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2020.

Based on Federated Hermes's 13F filing for Q3 2020, filed 12 Nov 2020.